评论
打印
Merck's Vioxx Nightmare
On Sept. 30, 2004, pharmaceutical giant Merck announced it would voluntarily recall its worldwide stock of Vioxx, an arthritis drug that had brought in $2.5 billion in sales the previous year. Merck executives said the recall was a precautionary measure spurred by a study that found patients who took the drug for at least 18 months incurred more heart attacks and strokes. In 2007, Merck paid $4.85 billion to settle 27,000 lawsuits from people affected by injuries or death associated with the drug.
默克万络（Vioxx）的噩梦
在2004年的9月30号，制药巨头默克公司宣布将自愿召回世界范围内的存货，这种治疗关节炎症的药物在过去的一年销售收入达25亿美元。默克的高级官员称此次召回是对一项研究结果的预防措施，该研究显示服药此药物超过18各月的患者将更有可能突发心脏病或中风。在2007年，默克公司为有关服用该药导致疾病或死亡的27000起诉讼付出了485亿美元。
